Reverse phase-liquid chromatography assisted protocol for simultaneous determination of lamivudine and tenofovir disoproxil fumarate in combined medication used to control HIV infection: an investigative approach

Reverse phase-liquid chromatography assisted protocol for simultaneous determination of lamivudine and tenofovir disoproxil fumarate in combined medication used to control HIV infection: an investigative approach

Abstract Background Human immunodeficiency virus (HIV) causes severe life-threatening condition, i.e., AIDS. HIV destabilises an individual’s ability to prevent infection. Therefore, the combine medication lamivudine (LVD) and tenofovir disoproxil fumarate (TDF) are prescribed to suppress the amount...

Full description

Bibliographic Details
Main Authors: Vaibhav S. Adhao, Suraj R. Chaudhari, Jaya P. Ambhore, Sunil Sangolkar, Raju R. Thenge, Rameshwar S. Cheke, Amod S. Patil
Format: Article
Language:English
Published: SpringerOpen 2021-04-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
HIV medication
Lamivudine
Tenofovir disoproxil fumarate
Liquid chromatography
Robustness
Online Access:https://doi.org/10.1186/s43094-021-00233-3

Internet

https://doi.org/10.1186/s43094-021-00233-3

Similar Items